Overview

A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets

Status:
Completed
Trial end date:
2019-12-10
Target enrollment:
Participant gender:
Summary
A Study to Determine the Drug Level Profile of Different formulations of BMS-986165 Tablets
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165
Famotidine